Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-07-10 5:00 pm Purchase | 13G | Autolus Therapeutics plc AUTL | Paradigm Biocapital Advisors LP | 10,098,584 5.8% | 10,098,584 (New Position) | View |
| 2023-03-20 09:13 am Purchase | 13G | Autolus Therapeutics plc AUTL | Tetragon Financial Management LP | 9,461,883 5.5% | 9,461,883 (New Position) | View |
| 2023-02-14 5:02 pm Purchase | 13G | Autolus Therapeutics plc AUTL | Nantahala Capital Management LLC | 7,782,018 4.7% | 3,704,509 (+90.85%) | View |
| 2023-02-14 12:09 pm Purchase | 13G | Autolus Therapeutics plc AUTL | Frazier Life Sciences Public Fund L.P. | 3,746,857 2.2% | 16,200 (+0.43%) | View |
| 2023-02-14 12:02 pm Purchase | 13G | Autolus Therapeutics plc AUTL | ARMISTICE CAPITAL LLC | 10,224,000 5.91% | 10,224,000 (New Position) | View |
| 2023-02-14 10:28 am Purchase | 13G | Autolus Therapeutics plc AUTL | Syncona Portfolio Ltd | 33,527,162 19.7% | 14,000,000 (+71.70%) | View |
| 2023-02-14 08:30 am Unchanged | 13G | Autolus Therapeutics plc AUTL | Deep Track Capital LP | 15,000,000 8.67% | 0 (Unchanged) | View |
| 2023-02-13 2:49 pm Sale | 13G | Autolus Therapeutics plc AUTL | Capital World Investors | 625,000 0.4% | -2,330,806 (-78.86%) | View |
| 2022-12-19 4:11 pm Purchase | 13G | Autolus Therapeutics plc AUTL | Deep Track Capital LP | 15,000,000 9.03% | 15,000,000 (New Position) | View |
| 2022-12-13 4:51 pm Purchase | 13D | Autolus Therapeutics plc AUTL | Blackstone Inc. BX | 23,750,917 14% | 2,500,000 (+11.76%) | View |
| 2022-12-13 4:50 pm Purchase | 13G | Autolus Therapeutics plc AUTL | Qatar Investment Authority | 15,000,000 9.03% | 15,000,000 (New Position) | View |
| 2022-10-05 4:21 pm Purchase | 13D | Autolus Therapeutics plc AUTL | PPF Biotech B.V. | 14,613,275 16.1% | 1,000 (+0.01%) | View |
| 2022-02-14 5:03 pm Purchase | 13G | Autolus Therapeutics plc AUTL | Nantahala Capital Management LLC | 4,077,509 5.6% | 4,077,509 (New Position) | View |
| 2022-02-11 12:21 pm Purchase | 13G | Autolus Therapeutics plc AUTL | Syncona Portfolio Ltd | 19,527,162 26.8% | 3,571,428 (+22.38%) | View |
| 2021-12-17 2:37 pm Purchase | 13G | Autolus Therapeutics plc AUTL | Frazier Life Sciences Public Fund L.P. | 3,730,657 5.1% | 3,730,657 (New Position) | View |
| 2021-11-16 4:07 pm Purchase | 13D | Autolus Therapeutics plc AUTL | Blackstone Inc. BX | 21,250,917 22.6% | 21,250,917 (New Position) | View |
| 2021-06-23 4:00 pm Purchase | 13D | Autolus Therapeutics plc AUTL | PPF Biotech B.V. | 14,612,275 27.9% | 361,255 (+2.53%) | View |
| 2021-02-17 5:01 pm Sale | 13D | Autolus Therapeutics plc AUTL | Arix Bioscience plc | 3,319,866 4.8% | -50,000 (-1.48%) | View |
| 2021-02-16 11:42 am Purchase | 13G | Autolus Therapeutics plc AUTL | Capital World Investors | 2,955,806 5.7% | 2,955,806 (New Position) | View |
| 2021-02-12 10:43 am Purchase | 13G | Autolus Therapeutics plc AUTL | Syncona Portfolio Ltd | 15,955,734 30.5% | 1,363,636 (+9.35%) | View |